Smoking history is associated to cognitive impairment in Parkinson's disease (Q38958979)

8 September 2017

Smoking history is associated to cognitive impairment in Parkinson's disease (English)

1 reference

8 September 2017

cognitive dysfunction

1 reference

Martine Simard

5

0 references

author name string

Maxime Doiron

1

1 reference

8 September 2017

Nicolas Dupré

2

1 reference

8 September 2017

Mélanie Langlois

3

1 reference

8 September 2017

Pierre Provencher

4

1 reference

8 September 2017

28 September 2015

1 reference

8 September 2017

Aging and Mental Health

1 reference

8 September 2017

21

1 reference

8 September 2017

3

1 reference

8 September 2017

322-326

1 reference

Cigarette smoking in Parkinson's disease: influence on disease progression

8 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Cognitive impairment in nondemented Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Neuropathology of cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Gut feelings about smoking and coffee in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Chronic cigarette smoking: implications for neurocognition and brain neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Smoking, dementia and cognitive decline in the elderly, a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Smoking, nicotine and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Vascular pathology in patients with idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Pooled analysis of tobacco use and risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

The economic impact of cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

Validation of the Montreal cognitive assessment versus mini-mental state examination against hypertension and hypertensive arteriopathy after transient ischemic attack or minor stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

A pilot study of risk factors for dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13607863.2015.1090393

10.1080/13607863.2015.1090393

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference